CB-839: Updated Phase I data

Updated from a cohort of 15 evaluable patients with metastatic triple-negative breast cancer (TNBC) in the open-label,

Read the full 172 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE